Open AccessIron oxide/gold nanoparticles‐decorated reduced graphene oxide nanohybrid as the thermo‐radiotherapy agent
Author(s) -
Moloudi Kave,
Samadian Hadi,
Jaymand Mehdi,
Khodamoradi Ehsan,
HoseiniGhahfarokhi Mojtaba,
Fathi Farshid
Publication year - 2020
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.366
H-Index - 38
eISSN - 1751-875X
pISSN - 1751-8741
DOI - 10.1049/iet-nbt.2020.0106
Subject(s) - graphene , nanoparticle , oxide , materials science , nanotechnology , colloidal gold , iron oxide , iron oxide nanoparticles , chemical engineering , metallurgy , engineering
The main focus of the current study is the fabrication of a multifunctional nanohybrid based on graphene oxide (GO)/iron oxide/gold nanoparticles (NPs) as the combinatorial cancer treatment agent. Gold and iron oxide NPs formed on the GONPs via the in situ synthesis approach. The characterisations showed that gold and iron oxide NPs formed onto the GO. Cell toxicity assessment revealed that the fabricated nanohybrid exhibited negligible toxicity against MCF‐7 cells in low doses (<50 ppm). Temperature measurement showed a time and dose‐dependent heat elevation under the interaction of the nanohybrid with the radio frequency (RF) wave. The highest temperature was recorded using 200 ppm concentration nanohybrid during 40 min exposure. The combinatorial treatments demonstrated that the maximum cell death (average of 53%) was induced with the combination of the nanohybrid with RF waves and radiotherapy (RT). The mechanistic study using the flow cytometry technique illustrated that early apoptosis was the main underlying cell death. Moreover, the dose enhancement factor of 1.63 and 2.63 were obtained from RT and RF, respectively. To sum up, the authors’ findings indicated that the prepared nanohybrid could be considered as multifunctional and combinatorial cancer therapy agents.